Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgA Nephropathy”

283 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 283 results

Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Testing effectiveness (Phase 2)Study completedNCT02942381
What this trial is testing

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Who this might be right for
IgA PatientsHydroxychloroquine
Peking University First Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04042623
What this trial is testing

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Aravive, Inc. 1
Large-scale testing (Phase 3)Looking for participantsNCT07390123
What this trial is testing

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 370
Not applicableNot Yet RecruitingNCT07481084
What this trial is testing

IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 80
Not applicableStudy completedNCT02527902
What this trial is testing

Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy

Who this might be right for
IGA Glomerulonephritis
Centre Hospitalier Universitaire de Saint Etienne 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04557462
What this trial is testing

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Novartis Pharmaceuticals 448
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Not applicableLooking for participantsNCT06654596
What this trial is testing

Efficacy and Safety of Telitacicept in IgAN

Who this might be right for
IgA Nephropathy (IgAN)Kidney DiseasesTelitacicept+1 more
Ruijin Hospital 118
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553494
What this trial is testing

SLN12140 in Adult Participants With IgA Nephropathy in China

Who this might be right for
IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc. 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770815
What this trial is testing

Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07541287
What this trial is testing

JADE101 in Participants With Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Jade Biosciences, Inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT07014826
What this trial is testing

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 378
Large-scale testing (Phase 3)Looking for participantsNCT06819826
What this trial is testing

SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

Who this might be right for
IgA Nephropathy (IgAN)
Biocity Biopharmaceutics Co., Ltd. 360
Not applicableUnknownNCT05383547
What this trial is testing

Bortezomib for Treating Glomerular Diseases

Who this might be right for
BortezomibGlomerulonephritisMN+3 more
Ruijin Hospital 20
Next Page